Archives
- 2026-11
- 2026-10
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
SB-3CT and the MMP9–PNN Plasticity Axis
2026-11-19
Mouse visual-cortex evidence places Adamtsl3 upstream of MMP9-dependent perineuronal-net maintenance and adult cortical plasticity. SB-3CT is relevant as a gelatinase-pathway probe, but the available comparison does not establish exclusive MMP9 causality, compound-specific efficacy, or direct relevance to human schizophrenia.
What GLYX 13 Reveals About NMDA Signaling
2026-11-19
GLYX 13 is best interpreted as a molecular probe of NMDA receptor signaling. Its documented partial-agonist classification supports receptor-level questions about glutamatergic neurotransmission, while downstream effects on synaptic plasticity, cells, circuits, or behavior require separate evidence.
How Tipranavir Potency Data Connect
2026-11-18
Tipranavir’s biochemical, cellular, resistance, pharmacokinetic and clinical observations answer different scientific questions. Read together, they support a mechanism-based interpretation of HIV protease inhibition while showing why enzyme potency alone cannot establish systemic exposure or clinical benefit.
CCR7–Notch1 Crosstalk in Mammary Cancer Stemness
2026-11-18
A preclinical mouse-model study examined whether CCR7 promotes mammary cancer stemness through Notch1 signaling. The findings support functional pathway crosstalk in tumor-derived cells, while remaining model-specific and mechanistic rather than clinical.
How BCL-2 Binding Relates to Cell Death
2026-11-17
TW-37 is documented as a BH3-groove binder with reported activity against several BCL-2-family proteins. Its binding constants support a molecular interaction model, while the reported cell-cycle, apoptosis, signaling and angiogenesis findings describe downstream biological consequences that remain context dependent.
Quantifying Organelle Proximity by Super-Resolution
2026-11-16
A methods-focused study shows how Airyscan and structured illumination imaging, combined with feature-based pixel classification, can improve the representation and quantitative analysis of organelle morphology and proximity. The evidence supports a reproducible image-analysis strategy in the evaluated datasets, while mask overlap remains an indirect indicator rather than proof of molecular tethering.
How Esomeprazole Sodium Lowers Acid
2026-11-16
Esomeprazole Sodium is documented as an H+/K+ ATPase inhibitor whose molecular action provides a plausible explanation for reduced gastric acid secretion. The evidence supports a mechanistic interpretation, while clinical outcomes, comparative performance, and product-specific efficacy require separate study.
How Cathepsin-Cleavable ADC Linkers Release Payloads
2026-11-15
What does a cathepsin-cleavable ADC peptide linker establish about targeted payload release? The key distinction is between chemical cleavage, intracellular liberation of a payload, and the later biological response of a cancer cell.
How Apogossypolone Links Binding to Cell Death
2026-11-14
Apogossypolone is documented as a multi-target inhibitor of antiapoptotic Bcl-2-family proteins. Its reported binding values, cell-based potency measurements, and apoptosis-related findings support a mechanistic interpretation, while differences among assays and cancer models limit direct comparison.
How Sorbitol Changes Osmotic Readouts
2026-11-13
Sorbitol can alter biochemical and cellular measurements through physicochemical effects on water activity, osmotic balance, hydration, and ice-related stress. Interpreting those changes requires separating direct effects on the assay environment from model-specific biological responses.
How Fenretinide Links FAK Signaling to Cancer Readouts
2026-11-13
Fenretinide, also called 4HPR, is described as a synthetic retinoid whose reported cancer-related effects include changes in cell growth, apoptosis-associated measurements, and migration signaling. Interpreting these observations requires separating a proposed FAK-centered mechanism from assay-specific responses and from metabolic findings in animal models.
What 5-EdU Shows in Spinal Cord Repair
2026-11-12
5-Ethynyl-2'-deoxyuridine (5-EdU) is a sensitive marker of newly synthesized DNA, but an EdU-positive signal is not equivalent to completed cell division or tissue repair. In a mouse spinal cord injury study, EdU-associated proliferation measurements contributed to a broader genetic, histological, transcriptional and functional analysis of astrocyte–microglia communication through CSF1 and IFN-β.
How Sephin1 May Prolong Stress Signaling
2026-11-12
Sephin1 is documented as disrupting the stress-responsive PPP1R15A–PP1c complex, prolonging eIF2α phosphorylation, and improving disease-associated readouts in two mouse proteostasis models. These findings support a target-linked mechanism, but their model-specific nature limits conclusions about broader efficacy.
What (R)-MG132 Can—and Cannot—Show
2026-11-11
Published evidence supports a lactate–HNRNPU K181 lactylation–PHGDH axis in cervical cancer, but the pharmacological findings center on pazopanib rather than (R)-MG132. The latter has a narrower interpretive role as a low-activity MG-132 enantiomer for proteasome-dependence controls, not as evidence that establishes the lactylation mechanism.
How to Interpret Paroxetine HCl Readouts
2026-11-11
Paroxetine Hydrochloride connects serotonin-transporter inhibition with distinct GRK2, ERK, cellular, and animal serotonin measurements. These readouts support different mechanistic claims and should not be treated as interchangeable evidence of clinical efficacy.